Skip to main content

Rezolute, Inc.

RZLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001509261

No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.

Superinvestors holding RZLT, Q2 2026

See all superinvestors

No superinvestor reported holding RZLT in Q2 2026.